SUMOylation inhibitor could lead to highly effective ways to treat the flu and other respiratory viruses
It happens every year, especially in winter. A virus saunters into your wide-open respiratory tract, worms its way into lung cells, and, next thing you know, you’re lying in bed with a fever, aches, and chills—classic symptoms of influenza, or flu.
Research led by UC Riverside bioengineers may help stop that cycle. The team has just found a way to block one strain of the influenza virus from accessing a human protein it needs to replicate in cells. The discovery could lead to highly effective ways to treat the flu and could also apply to other respiratory viruses, such as SARS-CoV-2, which causes Covid-19… Continue reading.
WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Jiayu Liao, Ph.D., Associate Professor;, Bioengineering, University of California, to its College of Fellows. Dr. Liao was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions to Class B GPCR, SUMOylation,quantitative FRET technologies, high-throughput screening and drug discoveries.